GCM
Ghisallo Capital Management Portfolio holdings
AUM
$3.74B
1-Year Return
32.47%
This Quarter Return
-3.93%
1 Year Return
+32.47%
3 Year Return
+84.41%
5 Year Return
–
10 Year Return
–
AUM
$979M
AUM Growth
+$141M
(+17%)
Cap. Flow
+$178M
Cap. Flow
% of AUM
18.18%
Top 10 Holdings %
Top 10 Hldgs %
51.65%
Holding
173
New
54
Increased
7
Reduced
11
Closed
58
Top Buys
| 1 |
Rollins
ROL
|
$93.3M |
| 2 |
Arm
ARM
|
$64.2M |
| 3 |
Enbridge
ENB
|
$58.9M |
| 4 |
AerCap
AER
|
$46M |
| 5 |
Carlyle Group
CG
|
$19.6M |
Top Sells
| 1 |
RenaissanceRe
RNR
|
$19.8M |
| 2 |
Agilon Health
AGL
|
$17.3M |
| 3 |
Everest Group
EG
|
$17.1M |
| 4 |
Cencora
COR
|
$16.4M |
| 5 |
CCC Intelligent Solutions
CCCS
|
$15.6M |
Sector Composition
| 1 | Consumer Discretionary | 22.02% |
| 2 | Technology | 18.1% |
| 3 | Energy | 14.52% |
| 4 | Industrials | 14.19% |
| 5 | Financials | 9.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
Coherus Oncology, Inc. Common Stock
CHRS
$150M
| – | – |
-150,000
| Closed | -$641K |
|
|
127
Cencora
COR
$56.7B
| – | – |
-85,000
| Closed | -$16.4M |
|
128
CorMedix
CRMD
$926M
| – | – |
-250,000
| Closed | -$991K |
|
129
CureVac
CVAC
$1.21B
| – | – |
-100,000
| Closed | -$1.04M |
|
130
Clearwater Analytics
CWAN
$6.07B
| – | – |
-300,000
| Closed | -$4.76M |
|
131
Ducommun
DCO
$1.35B
| – | – |
-50,000
| Closed | -$2.18M |
|
132
Editas Medicine
EDIT
$248M
| – | – |
-974,618
| Closed | -$8.02M |
|
|
133
Everest Group
EG
$14.3B
| – | – |
-50,000
| Closed | -$17.1M |
|
134
Enlight Renewable Energy
ENLT
$3.82B
| – | – |
-28,223
| Closed | -$501K |
|
135
EverCommerce
EVCM
$2.06B
| – | – |
-75,000
| Closed | -$888K |
|
136
EVgo
EVGO
$529M
| – | – |
-500,000
| Closed | -$2M |
|
137
Global E Online
GLBE
$6.07B
| – | – |
-100,000
| Closed | -$4.09M |
|
138
SPDR Gold Trust
GLD
$112B
| – | – |
-16,200
| Closed | -$2.89M |
|
139
Gulfport Energy Corp
GPOR
$3.08B
| – | – |
-55,000
| Closed | -$5.78M |
|
140
Hayward Holdings
HAYW
$3.52B
| – | – |
-200,000
| Closed | -$2.57M |
|
|
HSAI
141
Hesai Group
HSAI
$3.52B
| – | – |
-150,000
| Closed | -$1.58M |
|
142
Integral Ad Science
IAS
$1.45B
| – | – |
-200,000
| Closed | -$3.6M |
|
143
Disc Medicine
IRON
$2.11B
| – | – |
-20,000
| Closed | -$888K |
|
144
Keurig Dr Pepper
KDP
$38.9B
| – | – |
-200,000
| Closed | -$6.25M |
|
145
Kimbell Royalty Partners
KRP
$1.25B
| – | – |
-75,000
| Closed | -$1.1M |
|
146
Kura Oncology
KURA
$713M
| – | – |
-45,000
| Closed | -$476K |
|
147
Kymera Therapeutics
KYMR
$3.11B
| – | – |
-50,000
| Closed | -$1.15M |
|
148
Lucid Motors
LCID
$5.66B
| – | – |
-200,000
| Closed | -$13.8M |
|
149
Lexicon Pharmaceuticals
LXRX
$396M
| – | – |
-500,000
| Closed | -$1.15M |
|
150
MKS Inc. Common Stock
MKSI
$7.02B
| – | – |
-20,476
| Closed | -$2.21M |
|